Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?

(2015) Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option? Jama Neurology. pp. 1407-1408. ISSN 2168-6149

Full text not available from this repository.

Abstract

Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?

Item Type: Article
Keywords: rituximab
Page Range: pp. 1407-1408
Journal or Publication Title: Jama Neurology
Journal Index: ISI
Volume: 72
Number: 12
Identification Number: https://doi.org/10.1001/jamaneurol.2015.2869
ISSN: 2168-6149
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/4457

Actions (login required)

View Item View Item